Literature DB >> 1915502

Maternal phenylketonuria syndrome in cousins caused by mild, unrecognized phenylketonuria in their mothers homozygous for the phenylalanine hydroxylase Arg-261-Gln mutation.

A Superti-Furga1, B Steinmann, G Duc, R Gitzelmann.   

Abstract

Intrauterine growth retardation, microcephaly, and developmental delay in two first cousins lead to the recognition of phenylketonuria (PKU) in their mothers, 24- and 23 year-old sisters with blood phenylalanine concentrations of approx. 1.2 mmol/l who had never been treated and had no overt mental retardation. Both mothers were shown to be homozygous for a point mutation leading to an Arg-to-Gln substitution at codon 261 of the phenylalanine hydroxylase gene, a mutation which has been recently identified and tentatively associated with a mild variant of PKU. Our observation suggests that homozygosity for the Arg-261-Gln mutation can indeed result in "mild" PKU with little or perhaps no mental retardation, but also indicates that in such women, who may go unrecognized if not screened for, blood phenylalanine is elevated enough to cause the maternal PKU syndrome in their offspring.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915502     DOI: 10.1007/bf01958431

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  20 in total

Review 1.  Heterogeneity of phenylketonuria at the clinical, protein and DNA levels.

Authors:  R G Cotton
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 2.  The polymerase chain reaction. A new method of using molecular genetics for medical diagnosis.

Authors:  B I Eisenstein
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

3.  Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase.

Authors:  S C Kwok; F D Ledley; A G DiLella; K J Robson; S L Woo
Journal:  Biochemistry       Date:  1985-01-29       Impact factor: 3.162

4.  Effects of untreated maternal hyperphenylalaninemia on the fetus: further study of families identified by routine cord blood screening.

Authors:  S E Waisbren; H L Levy
Journal:  J Pediatr       Date:  1990-06       Impact factor: 4.406

5.  A beta-thalassemia gene caused by a 290-base pair deletion: analysis by direct sequencing of enzymatically amplified DNA.

Authors:  R Spiegelberg; C Aulehla-Scholz; H Erlich; J Horst
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

6.  Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria.

Authors:  A G DiLella; J Marvit; A S Lidsky; F Güttler; S L Woo
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

7.  Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

Authors:  R R Lenke; H L Levy
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

Review 8.  A novel method for detecting point mutations or polymorphisms and its application to population screening for carriers of phenylketonuria.

Authors:  S S Sommer; J D Cassady; J L Sobell; C D Bottema
Journal:  Mayo Clin Proc       Date:  1989-11       Impact factor: 7.616

9.  Correlation between polymorphic DNA haplotypes at phenylalanine hydroxylase locus and clinical phenotypes of phenylketonuria.

Authors:  F Güttler; F D Ledley; A S Lidsky; A G DiLella; S E Sullivan; S L Woo
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

10.  Missense mutations associated with RFLP haplotypes 1 and 4 of the human phenylalanine hydroxylase gene.

Authors:  Y Okano; T Wang; R C Eisensmith; B Steinmann; R Gitzelmann; S L Woo
Journal:  Am J Hum Genet       Date:  1990-01       Impact factor: 11.025

View more
  6 in total

1.  Microcephaly and maternal phenylketonuria.

Authors:  A Superti-Furga; B Steinmann; G Duc; R Gitzelmann
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

2.  Pearson bone marrow-pancreas syndrome with insulin-dependent diabetes, progressive renal tubulopathy, organic aciduria and elevated fetal haemoglobin caused by deletion and duplication of mitochondrial DNA.

Authors:  A Superti-Furga; E Schoenle; P Tuchschmid; R Caduff; V Sabato; D DeMattia; R Gitzelmann; B Steinmann
Journal:  Eur J Pediatr       Date:  1993-01       Impact factor: 3.183

3.  Phenylketonuria: variable phenotypic outcomes of the R261Q mutation and maternal PKU in the offspring of a healthy homozygote.

Authors:  S Kleiman; L Vanagaite; J Bernstein; G Schwartz; N Brand; A Elitzur; S L Woo; Y Shiloh
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

4.  A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.

Authors:  A Superti-Furga; G Eich; H U Bucher; J Wisser; A Giedion; R Gitzelmann; B Steinmann
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

5.  In vivo assessment of mutations in the phenylalanine hydroxylase gene by phenylalanine loading: characterization of seven common mutations.

Authors:  P Guldberg; I Mikkelsen; K F Henriksen; H C Lou; F Güttler
Journal:  Eur J Pediatr       Date:  1995-07       Impact factor: 3.183

6.  Phenylketonuria genotypes correlated to metabolic phenotype groups in Norway.

Authors:  H G Eiken; P M Knappskog; K Motzfeldt; H Boman; J Apold
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.